TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TBG Diagnostics Ltd (TDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10134
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers and bone marrow registry labs worldwide. It has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others to expand market presence and product portfolio. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia.

TBG Diagnostics Ltd (TDL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Progen Pharma Enters Into Licensing Agreement With Medigen Biotech For PG545 11
Beta Therapeutics Enters into Licensing Agreement with Progen Pharma 12
Equity Offering 13
Progen Pharma Raises USD9 Million in Public Offering of Shares 13
Progen Pharma Completes Rights Issue Of Common Stock For US$5.4 Million 14
Acquisition 15
Zucero Therapeutics Acquires Progen PG500 Series from TBG Diagnostics 15
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 16
TBG Diagnostics Ltd – Key Competitors 17
TBG Diagnostics Ltd – Key Employees 18
TBG Diagnostics Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Legal and Regulatory 20
Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Progen Pharma Enters Into Licensing Agreement With Medigen Biotech For PG545 11
Beta Therapeutics Enters into Licensing Agreement with Progen Pharma 12
Progen Pharma Raises USD9 Million in Public Offering of Shares 13
Progen Pharma Completes Rights Issue Of Common Stock For US$5.4 Million 14
Zucero Therapeutics Acquires Progen PG500 Series from TBG Diagnostics 15
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 16
TBG Diagnostics Ltd, Key Competitors 17
TBG Diagnostics Ltd, Key Employees 18
TBG Diagnostics Ltd, Other Locations 19
TBG Diagnostics Ltd, Subsidiaries 19

List of Figures
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sysmex Corp (6869):製薬・医療:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Rentokil Initial plc:企業の戦略・SWOT・財務分析
    Rentokil Initial plc - Strategy, SWOT and Corporate Finance Report Summary Rentokil Initial plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GeneNews Ltd (GEN):医療機器:M&Aディール及び事業提携情報
    Summary GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNew …
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kezar Life Sciences Inc (KZR):製薬・医療:M&Aディール及び事業提携情報
    Summary Kezar Life Sciences Inc (Kezar Life Sciences) is a clinical-stage biotechnology company that discovers and develops small molecule therapies to treat autoimmunity and cancer. The company’s lead product candidate, KZR-616, an immunoproteasome inhibitor intended for the treatment of various au …
  • GP JOULE GmbH:電力:M&Aディール及び事業提携情報
    Summary GP JOULE GmbH (GP JOULE) is an alternative energy company that offers natural resource conservation solutions. The company offers products such as solar carports and movers, and green house systems. Its services include planning, engineering, procurement, and construction, operations, and ma …
  • National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • Seair Inc:企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sermsuk Public Company Limited:企業の戦略・SWOT・財務分析
    Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Choice Spine LLC:製品パイプライン分析
    Summary Choice Spine LLC (Choice Spine) is a spinal implant company that develops, manufactures and markets surgeon focused systems. The company offers products which include cervical and thoracolumbar systems. Its cervical systems comprise plate systems, inter-body systems and fixation systems. Cho …
  • Goodman Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Goodman Co Ltd (Goodman), a subsidiary of Nipro Corp is a medical device company that develops, manufactures and distributes medical equipment and medical disposables. The company’s products include scoring equipment, semi-compliant systems, non-compliant systems, aspiration catheters, devic …
  • Celsense Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as …
  • Intellicheck, Inc. (IDN):企業の財務・戦略的SWOT分析
    Intellicheck, Inc. (IDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • Nu Skin Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bio Osmo Berhad:企業の戦略・SWOT・財務情報
    Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report Summary Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Streck Inc:企業の製品パイプライン分析2018
    Summary Streck Inc (Streck) is a developer and manufacturer of hematology, immunology and molecular biology products for clinical and research laboratories. The company provide products such as offers body fluid, sedimentation-rate, chemistry, whole blood, whole blood glucose and hemoglobin, instrum …
  • Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析
    Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆